Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[AL amyloidosis].

A R Hedeshi1, D Brenez, L Benaddia

  • 1Service de Médecine, H.I.S., Site Joseph Bracops, U.L.B.

Revue Medicale De Bruxelles
|March 17, 2001
PubMed
Summary

AL amyloidosis, a systemic disease from fibrillar protein deposits, presents varied symptoms and is often fatal. Current treatments are insufficient, necessitating further research into diagnosis and management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coexistence of renal malakoplakia and myelodysplastic syndrome.

Internal medicine journal·2012
Same author

Incidence of aflatoxins in Iran pistachio nuts.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2006
Same author

S-wave spin-triplet order in superconductors without inversion symmetry: Li2Pd3B and Li2Pt3B.

Physical review letters·2006
Same author

[Internal medicine and ophthalmology. The eye and drugs].

Revue medicale de Bruxelles·2001
Same author

[In-Hospital meeting of the AMUB (Association des Medecins anciens etudiants de l'Universite libre de Bruxelles): endocrine digestive tumors].

Revue medicale de Bruxelles·2000
Same author

International participation in major intensive care journals. "The smaller the better".

Intensive care medicine·1996

Area of Science:

  • Hematology
  • Nephrology
  • Cardiology

Background:

  • AL amyloidosis is a rare systemic disease characterized by the extracellular deposition of misfolded immunoglobulin light chains.
  • These fibrillar deposits lead to progressive organ damage and dysfunction, significantly impacting patient prognosis.

Observation:

  • Presents three distinct clinical cases of multisystemic AL amyloidosis.
  • Initial presentations included nephrotic syndrome, cardiac failure, and hepatic insufficiency, highlighting the diverse clinical manifestations.

Findings:

  • The study reviews the heterogeneous clinical features, diagnostic challenges, and current therapeutic strategies for AL amyloidosis.
  • Emphasizes the need for early and accurate diagnosis due to the potential for rapid disease progression and lethality.

Related Experiment Videos

Implications:

  • Highlights the limitations of current AL amyloidosis therapies, underscoring the urgent need for novel treatment approaches.
  • Suggests that understanding diverse presentations is crucial for timely diagnosis and improved patient outcomes in systemic amyloidosis.